Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Eon Labs, Inc. history
Eon Labs, Inc. company history timeline
Eon overcame Vitarine's legacy of errancy in September 1994, when the company was removed from the FDA's blacklist.
By the beginning of 1995, the company had 30 drugs in production, with applications filed for the introduction of 14 additional drugs.
Profits were growing steadily, eclipsing $5 million in 1999.
By the end of 2001, the company was marketing more than 80 generic drugs in various dosage strengths, ranking as one of the top five companies in the country in terms of gaining FDA approvals.
Eon's IPO was completed in June 2002, when it debuted on the NASDAQ at $15 per share.
In 2002, sales increased to $244 million and net income soared to $43.2 million, nearly three times the total posted a year earlier.
2002: Eon completes its initial public offering of stock, with Hexal remaining a majority owner.
In late November 2003, Eon received approval for Bupropion, the generic version of GlaxoSmithKline's 100-milligram antidepressant Wellbutrin.
By 2004, three of every four drugs produced by the company entered the market on the first day, or shortly thereafter, the patents for the branded drug expired.
Rate how well Eon Labs, Inc. lives up to its initial vision.
Eon Labs, Inc. jobs
Do you work at Eon Labs, Inc.?
Is Eon Labs, Inc.'s vision a big part of strategic planning?
Eon Labs, Inc. competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Sovereign Pharmaceuticals | 1990 | $52.7M | 100 | - |
| Contract Pharmacal | 1971 | $54.0M | 79 | 15 |
| PCI Synthesis | - | $1.1M | 7 | - |
| Eurofins | - | $4.9B | 48,000 | 510 |
| URL Pharma | 1946 | $38.0M | 211 | - |
| Nostrum Laboratories | 1995 | $15.0M | 148 | - |
| DSM Pharmaceuticals Inc | 1993 | $850.0M | 1,200 | - |
| Tedor Pharma | 2001 | $11.0M | 20 | - |
| STASON PHARMACEUTICALS | 1994 | $1.2M | 20 | - |
| Mayne Pharma | - | $780,000 | 10 | 11 |
Zippia gives an in-depth look into the details of Eon Labs, Inc., including salaries, political affiliations, employee data, and more, in order to inform job seekers about Eon Labs, Inc.. The employee data is based on information from people who have self-reported their past or current employments at Eon Labs, Inc.. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Eon Labs, Inc.. The data presented on this page does not represent the view of Eon Labs, Inc. and its employees or that of Zippia.
Eon Labs, Inc. may also be known as or be related to EON LABS, EON LABS INC and Eon Labs, Inc.